RT @JoseFlorezMDPhD: Honored, humbled and excited to become the inaugural Chair of @MassGenBrigham Department of Medicine @MGHMedicine @Bri….

How is biopharma R&D like Texas hold ‘em poker? My new PlengeGen blog discusses a critical inflection point in early clinical drug development and the investment required to deliver the necessary proof-of-concept data.

RT @embl: Congratulations, Edith Heard!. The EMBL Director General has been awarded the CNRS Gold Medal 2024 for her outstanding contributi….

A wrote a blog "advice to my younger self". I then uploaded the blog into Illuminate to create an AI podcast. Even if you don't like the advice, listen to the podcast. it is pretty amazing what AI can do!. AI podcast: Blog:

RT @DShaywitz: @jflier Really fascinating article on GLP1. Q1: given knowledge in 1997, do you think PFE approached decision in wrong way?….

RT @Atelfo: I've noticed that biotech cos built around a computational discovery platform have a different philosophy on company building a….

RT @_anuragverma: I’m thrilled to share that our work from the @VAResearch is finally out in @ScienceMagazine ! We dive deep into the genet….

RT @alltrna: Please join us in welcoming Chris Schade, Lynne Parshall, @rplenge, and @NancySimonian, who join @afzelius_lovisa and Michelle….

RT @ScienceAtBMS: Our Head of Research, @rplenge, explains the components of our strategic research framework and how our differentiated pl….

New on How our sequential immunotherapy research strategy @bmsnews strives to provide durable remissions and even functional cures for patients with #autoimmune diseases.

RT @zakkohane: Looking forward to exploring a successful transition from academia to industry with @rplenge this afternoon over food and d….

RT @HarvardDBMI: Tuesday 5/28/24: .Biomedical Informatics Entrepreneurs Salon #BIES hosted by @zakkohane w/ @HarvardTechXfer. 🍕🥤🍪 4:30pm In….

RT @PGCgenetics: New pre-print from the @PGCgenetics #Depression Group: Multi-ancestry GWAS of depression with 685,000 cases identifies 697….

RT @FishburnSimone: Another fascinating interview - with @rplenge, head of research at @bmsnews : Causal biology is the North Star of R&D.….

And link to the interview on YouTube is here: .

I had a great conversation with @FishburnSimone on The @BioCentury Show, covering the core components of our research framework at BMS, including causal human biology, matching modality to mechanism, and path to clinical proof of concept.

I had the pleasure of speaking with @NatRevDrugDisc about one of the topics I’m most passionate about: the potential of sequential immunotherapy to treat autoimmune diseases. We also discussed genetics and its role in causal human biology.

RT @HirotsuguOda215: Excited to share the first publication from Oda lab in @NatImmunol !! We describe human SHARPIN deficiency as a novel….

RT @ScienceAtBMS: We recently celebrated the "topping off” of our new San Diego R&D site, a key milestone that brings us closer to realizin….

RT @ScienceAtBMS: It takes thousands of people and billions of data points to bring ideas to life, which are the catalysts for advances as….